Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,886 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,267
Ph III recruiting: 131
Growth YoY: +4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,374)

clinicaltrialsPublishedShowing 301–350 of 842 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03774654	CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)	active not recruiting	Phase 1	13	Baylor College of MedicineOTHER	1	Jul 13, 2026	clinicaltrials
NCT04822337	Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma	active not recruiting	Phase 1 / Phase 2	70	Wake Forest University Health SciencesOTHER	1	Jul 13, 2026	clinicaltrials